Top Banner
Including Elderly Patients with NVAF and Long-Term Care OUR GUEST SPEAKER WILL BE Sean Cannone, DO, CMD Senior Vice President Consortium Concepts, LLC Copley, OH Dr. Sean Cannone is a paid speaker for Janssen Pharmaceuticals, Inc. DATE/TIME Tuesday September 12, 2017 7:30 PM LCATION Fleming's Prime Steakhouse 4000 Medina Road Akron, OH 44333 (330) 670-5200 RSVP: Please RSVP to your Janssen Representative before Tuesday, September 05, 2017 or visit http://www.medforcereg.net/SOMP119875 Zachary Gantz (724) 866-3996
2

Including Elderly Patients with NVAF and Long-Term Care...XARELTO@ is indicated to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation

Feb 25, 2021

Download

Documents

dariahiddleston
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Including Elderly Patients with NVAF and Long-Term Care...XARELTO@ is indicated to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation

Including Elderly Patients with NVAFand Long-Term Care

OUR GUEST SPEAKER WILL BESean Cannone, DO, CMDSenior Vice PresidentConsortium Concepts, LLCCopley, OH Dr. Sean Cannone is a paid speaker for Janssen Pharmaceuticals, Inc.

DATE/TIMETuesdaySeptember 12, 2017

7:30 PM LCATIONFleming's PrimeSteakhouse4000 Medina RoadAkron, OH 44333 (330) 670-5200

RSVP:Please RSVP to yourJanssen Representative before Tuesday,September 05, 2017or visithttp://www.medforcereg.net/SOMP119875 Zachary Gantz(724) 866-3996

Page 2: Including Elderly Patients with NVAF and Long-Term Care...XARELTO@ is indicated to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation